TegoScience Inc (191420) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.066x

Based on the latest financial reports, TegoScience Inc (191420) has a cash flow conversion efficiency ratio of -0.066x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-3.18 Billion ≈ $-2.15 Million USD) by net assets (₩48.32 Billion ≈ $32.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See TegoScience Inc net asset quality index to measure how much of total assets are equity-financed.

TegoScience Inc - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how TegoScience Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 191420 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

TegoScience Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of TegoScience Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Zaklad Budowy Maszyn ZREMB-CHOJNICE S.A. WAR:ZRE	0.014x
B. Gaon Holdings Ltd TA:GAON	0.023x
Medicamen Biotech Limited NSE:MEDICAMEQ	0.013x
GiG Software PLC ST:GIG-SDB	-0.014x
Australian Vanadium Ltd AU:AVL	-0.040x
AKKO Invest Nyrt BUD:AKKO	0.073x
Mida Assets Public Company Limited BK:MIDA	-0.061x
GFM Services Bhd KLSE:0039	0.017x

Annual Cash Flow Conversion Efficiency for TegoScience Inc (2015–2025)

The table below shows the annual cash flow conversion efficiency of TegoScience Inc from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see TegoScience Inc stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩50.33 Billion ≈ $34.11 Million	₩-3.07 Billion ≈ $-2.08 Million	-0.061x	-162.02%
2024-12-31	₩49.86 Billion ≈ $33.79 Million	₩-1.16 Billion ≈ $-785.84K	-0.023x	-35.59%
2023-12-31	₩46.33 Billion ≈ $31.39 Million	₩-794.61 Million ≈ $-538.49K	-0.017x	-180.12%
2022-12-31	₩48.60 Billion ≈ $32.93 Million	₩1.04 Billion ≈ $705.01K	0.021x	+126.95%
2021-12-31	₩48.47 Billion ≈ $32.85 Million	₩457.25 Million ≈ $309.87K	0.009x	-63.89%
2020-12-31	₩48.99 Billion ≈ $33.20 Million	₩1.28 Billion ≈ $867.16K	0.026x	+2916.76%
2019-12-31	₩47.82 Billion ≈ $32.41 Million	₩41.40 Million ≈ $28.06K	0.001x	-95.15%
2018-12-31	₩46.68 Billion ≈ $31.63 Million	₩833.88 Million ≈ $565.11K	0.018x	-77.74%
2017-12-31	₩35.71 Billion ≈ $24.20 Million	₩2.87 Billion ≈ $1.94 Million	0.080x	-11.57%
2016-12-31	₩25.98 Billion ≈ $17.61 Million	₩2.36 Billion ≈ $1.60 Million	0.091x	-13.13%
2015-12-31	₩25.21 Billion ≈ $17.08 Million	₩2.63 Billion ≈ $1.78 Million	0.104x	--

About TegoScience Inc

KQ:191420 Korea Pharmaceuticals

Market Cap

$34.36 Million

₩50.71 Billion KRW

Market Cap Rank

#23224 Global

#1523 in Korea

Share Price

₩6280.00

Change (1 day)

+6.80%

52-Week Range

₩5600.00 - ₩18970.00

All Time High

₩71600.00